[Featured Stock] BioSmart Expected to Benefit from Subsidiary's Cosmetics Business Amid Hallyanryeong Lift Hopes

[Asia Economy Reporter Minwoo Lee] Biosmart's stock price is on the rise. This appears to be due to expectations that the easing of the Hanhanryeong (限韓令·Korean Wave ban) will be a positive factor for its subsidiary's cosmetics business in China.

As of 1:42 PM on the 30th, Biosmart's stock price recorded 5,670 KRW, up 7.28% from the previous day. The easing of the Hanhanryeong seems to have acted as a positive factor, as China's largest travel company Trip.com Group and the Korea Tourism Organization jointly launched promotions for tourism products.

The Korea Tourism Organization reportedly began selling Korean tourism products together with Trip.com's brand 'Ctrip' on the same day. One of Trip.com's co-founders, Chairman Liang Jianzhang, personally appeared to introduce travel destinations and featured Korean tourism products in the 'Super Boss Live Show,' where hotel accommodations and tourism products were sold at discounted prices. Since the Hanhanryeong began in 2017, this is the first time Korean tourism products are officially sold throughout China, raising expectations for the full resumption of tourism exchanges.

Hanseng Cosmetics, in which Biosmart holds a 65.2% stake, possesses numerous patents and Chinese health approval items based on its research and development capabilities related to anti-aging and antibacterial functions such as extracts from the Korean yellowwood tree, pine cone extracts, and nano-emulsion compositions. Lami Cosmetics, in which Biosmart holds a 95.5% stake, is also known to include China among its main trading countries.